>
Switch to:

Immunogen Total Stockholders Equity

: $-42.9 Mil (As of Sep. 2020)
View and export this data going back to 1989. Start your Free Trial

Immunogen's Total Stockholders Equity for the quarter that ended in Sep. 2020 was $-42.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Immunogen's Book Value per Share for the quarter that ended in Sep. 2020 was $-0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Immunogen's Debt-to-Equity for the quarter that ended in Sep. 2020 was -0.58.

Immunogen Total Stockholders Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Immunogen Annual Data
Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.30 -17.90 10.97 -76.12 89.57

Immunogen Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -76.12 -4.10 -24.52 -42.89 89.57

Immunogen  (NAS:IMGN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Immunogen's Book Value per Share for the quarter that ended in Sep. 2020 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-42.891-0)/174.508
=-0.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Immunogen's Debt-to-Equity for the quarter that ended in Sep. 2020 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(5.264 + 19.403) / -42.891
=-0.58

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Immunogen Total Stockholders Equity Related Terms

Immunogen Total Stockholders Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)